Achmea Investment Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-12,519
Closed -$277K – 646
2022
Q4
$277K Sell
12,519
-515
-4% -$13.9K 0.01% 527
2022
Q3
$330K Hold
13,034
– – 0.01% 532
2022
Q2
$433K Hold
13,034
– – 0.01% 505
2022
Q1
$940K Buy
+13,034
New +$939K 0.02% 460
2021
Q4
– Sell
-83,941
Closed -$10.6M – 567
2021
Q3
$10.6M Buy
+83,941
New +$12.2M 0.32% 74

Other funds holding TDOC

Achmea Investment Management's TDOC Position: Q1 2023 in Review

Achmea Investment Management sold out of Teladoc Health (TDOC) in Q1 2023, closing a stake of 12,519 shares — an estimated $277K sold.

Achmea Investment Management first reported a position in TDOC in Q3 2021 and held it in 5 quarters. The position peaked at $10.6M in Q3 2021. 429 funds tracked by Wall St. Rank hold TDOC as of Q1 2023.

  • Achmea Investment Management reported no remaining Teladoc Health position as of Q1 2023 after selling out during the quarter.
  • Achmea Investment Management sold 12,519 Teladoc Health shares in Q1 2023, an estimated $277K.
  • Achmea Investment Management first reported a position in Teladoc Health in Q3 2021 and held it in 5 quarters.
  • Achmea Investment Management's Teladoc Health position peaked at $10.6M in Q3 2021.
  • 429 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2023.

Based on Achmea Investment Management's 13F filing for Q1 2023, filed 4 May 2023.